Thymosin α-1 dosing schedule
Human schedule
Thymosin alpha-1 (thymalfasin) is given by subcutaneous injection after reconstituting the lyophilized powder. The figures below generalize from clinical studies (chiefly the Zadaxin chronic hepatitis B regimen) and described protocols.
This is a concise reference to regimens described for adults; it is not an individual prescription.
| Period / condition | Dose | Escalation |
|---|---|---|
| Core studied regimen | 1.6 mg subcutaneous, twice weekly (3–4 days apart) | Starting dose |
| Optional loading | 1.6 mg subcutaneous daily, short initial period | Increase if needed |
| Maintenance | 1.6 mg subcutaneous, twice weekly | Maximum in this schedule |